Women with elevated breast cancer risk could see mortality benefit from estrogen-blocking drugs
While it has long been recognized that drugs that block the cancer-promoting activity of estrogen reduce risk of developing new breast cancers, a new computer modeling study has shown that these treatments could also reduce the risk of dying from the disease in women who are at high risk.
Materials provided by Georgetown University Medical Center. Note: Content may be edited for style and length.
Source link aaaaa